These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26599631)

  • 1. Development of the CHARIOT Research Register for the Prevention of Alzheimer's Dementia and Other Late Onset Neurodegenerative Diseases.
    Larsen ME; Curry L; Mastellos N; Robb C; Car J; Middleton LT
    PLoS One; 2015; 10(11):e0141806. PubMed ID: 26599631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol of the Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research (CHARIOT): Prospective Readiness cOhort (PRO) SubStudy.
    Udeh-Momoh CT; Watermeyer T; Price G; de Jager Loots CA; Reglinska-Matveyev N; Ropacki M; Ketter N; Fogle M; Raghavan N; Arrighi M; Brashear R; Di J; Baker S; Giannakopoulou P; Robb C; Bassil D; Cohn M; McLellan-Young H; Crispin J; Lakey K; Lisa C; Chowdary Seemulamoodi Y; Kafetsouli D; Perera D; Car J; Majeed A; Ward H; Ritchie K; Perneczky R; Kivipelto M; Scott D; Bracoud L; Saad Z; Novak G; Ritchie CW; Middleton L
    BMJ Open; 2021 Jun; 11(6):e043114. PubMed ID: 34168021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD).
    Walter S; Clanton TB; Langford OG; Rafii MS; Shaffer EJ; Grill JD; Jimenez-Maggiora GA; Sperling RA; Cummings JL; Aisen PS
    J Prev Alzheimers Dis; 2020; 7(4):219-225. PubMed ID: 32920623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Alzheimer's Prevention Registry: A Large Internet-Based Participant Recruitment Registry to Accelerate Referrals to Alzheimer's-Focused Studies.
    Langbaum JB; High N; Nichols J; Kettenhoven C; Reiman EM; Tariot PN
    J Prev Alzheimers Dis; 2020; 7(4):242-250. PubMed ID: 32920626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.
    Vermunt L; Veal CD; Ter Meulen L; Chrysostomou C; van der Flier W; Frisoni GB; Guessous I; Kivipelto M; Marizzoni M; Martinez-Lage P; Molinuevo JL; Porteous D; Ritchie K; Scheltens P; Ousset PJ; Ritchie CW; Luscan G; Brookes AJ; Visser PJ
    Alzheimers Dement; 2018 Jun; 14(6):837-842. PubMed ID: 29604264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings.
    Vermunt L; Muniz-Terrera G; Ter Meulen L; Veal C; Blennow K; Campbell A; Carrié I; Delrieu J; Fauria K; Huesa Rodríguez G; Ingala S; Jenkins N; Molinuevo JL; Ousset PJ; Porteous D; Prins ND; Solomon A; Tom BD; Zetterberg H; Zwan M; Ritchie CW; Scheltens P; Luscan G; Brookes AJ; Visser PJ;
    Alzheimers Res Ther; 2020 Jan; 12(1):8. PubMed ID: 31907067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the quality of care for mild to moderate dementia: an evaluation of the Croydon Memory Service Model.
    Banerjee S; Willis R; Matthews D; Contell F; Chan J; Murray J
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):782-8. PubMed ID: 17243196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project.
    Ritchie CW; Molinuevo JL; Truyen L; Satlin A; Van der Geyten S; Lovestone S;
    Lancet Psychiatry; 2016 Feb; 3(2):179-86. PubMed ID: 26683239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing the motivations of patients with dementia and cognitive impairment and their carers in joining a dementia research register (DemReg).
    Avent C; Curry L; Gregory S; Marquardt S; Pae L; Wilson D; Ritchie K; Ritchie CW
    Int Psychogeriatr; 2013 Jun; 25(6):963-71. PubMed ID: 23510651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is late-onset schizophrenia related to neurodegenerative processes? A review of literature].
    Lagodka A; Robert P
    Encephale; 2009 Sep; 35(4):386-93. PubMed ID: 19748376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics.
    Sano M; Jacobs D; Andrews H; Bell K; Graff-Radford N; Lucas J; Rabins P; Bolla K; Tsai WY; Cross P; Andrews K; Costa R; Xiaodong Luo
    Clin Trials; 2008; 5(5):523-33. PubMed ID: 18827045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and demographic characteristics of the cases of dementia diagnosed in the Health District of Girona throughout the period 2007-2010: data from the Girona Dementia Registry (ReDeGi)].
    Calvo-Perxas L; Osuna MT; Gich J; Eligio-Hernandez E; Linares M; Vinas M; Casas I; Turro-Garriga O; Lopez-Pousa S; Garre-Olmo J;
    Rev Neurol; 2012 Apr; 54(7):399-406. PubMed ID: 22451126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
    Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
    Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of a risk assessment approach to the prevention of Alzheimer's disease and dementia.
    Anstey KJ; Eramudugolla R; Dixon RA
    J Alzheimers Dis; 2014; 42 Suppl 4():S463-73. PubMed ID: 25114084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age of major depression onset, depressive symptoms, and risk for subsequent dementia: results of the German study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe).
    Heser K; Tebarth F; Wiese B; Eisele M; Bickel H; Köhler M; Mösch E; Weyerer S; Werle J; König HH; Leicht H; Pentzek M; Fuchs A; Riedel-Heller SG; Luppa M; Prokein J; Scherer M; Maier W; Wagner M;
    Psychol Med; 2013 Aug; 43(8):1597-610. PubMed ID: 23137390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residential distance to high-voltage power lines and risk of neurodegenerative diseases: a Danish population-based case-control study.
    Frei P; Poulsen AH; Mezei G; Pedersen C; Cronberg Salem L; Johansen C; Röösli M; Schüz J
    Am J Epidemiol; 2013 May; 177(9):970-8. PubMed ID: 23572049
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.